Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

613 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Advisory Group recommendations on priorities for the IARC Monographs.
Berrington de González A, Masten SA, Bhatti P, Fortner RT, Peters S, Santonen T, Yakubovskaya MG, Barouki R, Barros SBM, Barupal D, Beane Freeman LE, Calaf GM, Dillner J, El Rhazi K, Fritschi L, Fukushima S, Godderis L, Kogevinas M, Lachenmeier DW, Mandrioli D, Muchengeti MM, Niemeier RT, Pappas JJ, Pi J, Purdue MP, Riboli E, Rodríguez T, Schlünssen V, Benbrahim-Tallaa L, de Conti A, Facchin C, Pasqual E, Wedekind R, Ahmadi A, Chittiboyina S, Herceg Z, Kulasingam S, Lauby-Secretan B, MacLehose R, Sanaa M, Schüz J, Suonio E, Zavadil J, Mattock H, Madia F, Schubauer-Berigan MK. Berrington de González A, et al. Among authors: dillner j. Lancet Oncol. 2024 May;25(5):546-548. doi: 10.1016/S1470-2045(24)00208-0. Epub 2024 Apr 12. Lancet Oncol. 2024. PMID: 38621402 No abstract available.
Immunogenicity and safety of the fourth dose of quadrivalent human papillomavirus (HPV) vaccine in immunosuppressed women who did not seroconvert after three doses.
Moreira Dos Santos LZ, Rodrigues CCM, Miyaji KT, Infante V, Picone CM, Lara AN, Eklund C, Kann H, Dillner J, Mayaud P, Sartori AMC. Moreira Dos Santos LZ, et al. Among authors: dillner j. Front Cell Infect Microbiol. 2024 Dec 18;14:1451308. doi: 10.3389/fcimb.2024.1451308. eCollection 2024. Front Cell Infect Microbiol. 2024. PMID: 39744156 Free PMC article.
Quadrivalent HPV (4vHPV) vaccine immunogenicity and safety in women using immunosuppressive drugs due to solid organ transplant.
Miyaji KT, Infante V, Picone CM, Dillner J, Kann H, Eklund C, Levi JE, de Oliveira ACS, Lara AN, Kawakami LS, Tacla M, Castanheira CP, Mayaud P, Sartori AMC. Miyaji KT, et al. Among authors: dillner j. Front Cell Infect Microbiol. 2024 Nov 4;14:1452916. doi: 10.3389/fcimb.2024.1452916. eCollection 2024. Front Cell Infect Microbiol. 2024. PMID: 39559707 Free PMC article. Clinical Trial.
Head-to-head comparison of two human papillomavirus vaccines for efficacy against cervical intraepithelial neoplasia grade 3 and adenocarcinoma in situ-population-based follow-up of two cluster-randomized trials.
Lehtinen M, Gray P, Luostarinen T, Eriksson T, Apter D, Bly A, Harjula K, Heikkilä K, Hokkanen M, Kuortti M, Nieminen P, Nummela M, Paavonen J, Palmroth J, Petäjä T, Pimenoff VN, Pukkala E, Dillner J. Lehtinen M, et al. Among authors: dillner j. Front Cell Infect Microbiol. 2024 Sep 9;14:1437704. doi: 10.3389/fcimb.2024.1437704. eCollection 2024. Front Cell Infect Microbiol. 2024. PMID: 39315334 Free PMC article. Clinical Trial.
613 results